Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apomorphine for Pain in Parkinson's Disease
NCT04879134Phase 3Unknown
- Sponsor
- University of Calgary
- Start
- Feb 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apomorphine in Parkinson's disease (PD), sponsored by University of Calgary. Status: unknown.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT04879134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04879134.